progesterone: be prescribed during pregnancy

from Quasimodo
0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Related concepts

Parents hormone
Weight: 0.73
, drug
Weight: 0.57
, ingredient
Weight: 0.56
, substance
Weight: 0.55
Siblings estrogen
Weight: 0.39
, glucocorticoid
Weight: 0.39
, oxytocin
Weight: 0.39
, vasopressin
Weight: 0.38
, prolactin
Weight: 0.38

Related properties

Property Similarity
be prescribed during pregnancy 1.00
be prescribed in pregnancy 0.99
be prescribed in early pregnancy 0.98
be prescribed during menopause 0.90
during pregnancy 0.89
be used in pregnancy 0.89
be given during pregnancy 0.89
be prescribed after iui 0.88
be important during pregnancy 0.88
be needed during pregnancy 0.88

Priors about this statement

Cues

0.2 0.4 0.6 0.8 Joint Necessity Sufficiency Implication Entailment Contradiction Entropy

Evidence

0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Clauses

Remarkability exclusitivity between siblings

0.11
Rule weight: 0.13
Evidence weight: 0.96
Similarity weight: 0.89
Evidence: 0.86
¬ Remarkable(progesterone, be prescribed during pregnancy)
Evidence: 0.05
¬ Remarkable(oxytocin, be used in pregnancy)

Remarkability from sibling implausibility

0.53
Rule weight: 0.60
Evidence weight: 0.99
Similarity weight: 0.89
Evidence: 0.61
Plausible(progesterone, be prescribed during pregnancy)
Evidence: 0.05
Remarkable(oxytocin, be used in pregnancy)
Evidence: 0.04
¬ Plausible(oxytocin, be used in pregnancy)

Salient implies Plausible

0.19
Rule weight: 0.28
Evidence weight: 0.68
Similarity weight: 1.00
Evidence: 0.61
Plausible(progesterone, be prescribed during pregnancy)
Evidence: 0.82
¬ Salient(progesterone, be prescribed during pregnancy)

Similarity expansion

0.76
Rule weight: 0.85
Evidence weight: 0.92
Similarity weight: 0.98
Evidence: 0.86
Remarkable(progesterone, be prescribed during pregnancy)
Evidence: 0.60
¬ Remarkable(progesterone, be prescribed in early pregnancy)
0.75
Rule weight: 0.85
Evidence weight: 0.89
Similarity weight: 0.99
Evidence: 0.86
Remarkable(progesterone, be prescribed during pregnancy)
Evidence: 0.84
¬ Remarkable(progesterone, be prescribed in pregnancy)
0.71
Rule weight: 0.85
Evidence weight: 0.84
Similarity weight: 0.99
Evidence: 0.82
Salient(progesterone, be prescribed during pregnancy)
Evidence: 0.85
¬ Salient(progesterone, be prescribed in pregnancy)
0.70
Rule weight: 0.85
Evidence weight: 0.92
Similarity weight: 0.89
Evidence: 0.50
Typical(progesterone, be prescribed during pregnancy)
Evidence: 0.16
¬ Typical(progesterone, be used in pregnancy)
0.69
Rule weight: 0.85
Evidence weight: 0.83
Similarity weight: 0.98
Evidence: 0.82
Salient(progesterone, be prescribed during pregnancy)
Evidence: 0.92
¬ Salient(progesterone, be prescribed in early pregnancy)
0.68
Rule weight: 0.85
Evidence weight: 0.89
Similarity weight: 0.90
Evidence: 0.86
Remarkable(progesterone, be prescribed during pregnancy)
Evidence: 0.79
¬ Remarkable(progesterone, be prescribed during menopause)
0.68
Rule weight: 0.85
Evidence weight: 0.90
Similarity weight: 0.88
Evidence: 0.86
Remarkable(progesterone, be prescribed during pregnancy)
Evidence: 0.73
¬ Remarkable(progesterone, be prescribed after iui)
0.68
Rule weight: 0.85
Evidence weight: 0.90
Similarity weight: 0.88
Evidence: 0.86
Remarkable(progesterone, be prescribed during pregnancy)
Evidence: 0.71
¬ Remarkable(progesterone, be important during pregnancy)
0.67
Rule weight: 0.85
Evidence weight: 0.88
Similarity weight: 0.89
Evidence: 0.86
Remarkable(progesterone, be prescribed during pregnancy)
Evidence: 0.90
¬ Remarkable(progesterone, during pregnancy)
0.67
Rule weight: 0.85
Evidence weight: 0.88
Similarity weight: 0.89
Evidence: 0.82
Salient(progesterone, be prescribed during pregnancy)
Evidence: 0.67
¬ Salient(progesterone, be used in pregnancy)
0.66
Rule weight: 0.85
Evidence weight: 0.87
Similarity weight: 0.89
Evidence: 0.82
Salient(progesterone, be prescribed during pregnancy)
Evidence: 0.68
¬ Salient(progesterone, during pregnancy)
0.66
Rule weight: 0.85
Evidence weight: 0.88
Similarity weight: 0.89
Evidence: 0.86
Remarkable(progesterone, be prescribed during pregnancy)
Evidence: 0.90
¬ Remarkable(progesterone, be given during pregnancy)
0.66
Rule weight: 0.85
Evidence weight: 0.88
Similarity weight: 0.88
Evidence: 0.86
Remarkable(progesterone, be prescribed during pregnancy)
Evidence: 0.85
¬ Remarkable(progesterone, be needed during pregnancy)
0.66
Rule weight: 0.85
Evidence weight: 0.87
Similarity weight: 0.89
Evidence: 0.86
Remarkable(progesterone, be prescribed during pregnancy)
Evidence: 0.95
¬ Remarkable(progesterone, be used in pregnancy)
0.65
Rule weight: 0.85
Evidence weight: 0.86
Similarity weight: 0.89
Evidence: 0.50
Typical(progesterone, be prescribed during pregnancy)
Evidence: 0.28
¬ Typical(progesterone, during pregnancy)
0.65
Rule weight: 0.85
Evidence weight: 0.86
Similarity weight: 0.89
Evidence: 0.82
Salient(progesterone, be prescribed during pregnancy)
Evidence: 0.74
¬ Salient(progesterone, be given during pregnancy)
0.64
Rule weight: 0.85
Evidence weight: 0.85
Similarity weight: 0.89
Evidence: 0.61
Plausible(progesterone, be prescribed during pregnancy)
Evidence: 0.39
¬ Plausible(progesterone, be used in pregnancy)
0.63
Rule weight: 0.85
Evidence weight: 0.83
Similarity weight: 0.90
Evidence: 0.82
Salient(progesterone, be prescribed during pregnancy)
Evidence: 0.93
¬ Salient(progesterone, be prescribed during menopause)
0.63
Rule weight: 0.85
Evidence weight: 0.84
Similarity weight: 0.88
Evidence: 0.82
Salient(progesterone, be prescribed during pregnancy)
Evidence: 0.87
¬ Salient(progesterone, be needed during pregnancy)
0.63
Rule weight: 0.85
Evidence weight: 0.82
Similarity weight: 0.89
Evidence: 0.61
Plausible(progesterone, be prescribed during pregnancy)
Evidence: 0.45
¬ Plausible(progesterone, during pregnancy)
0.63
Rule weight: 0.85
Evidence weight: 0.83
Similarity weight: 0.89
Evidence: 0.50
Typical(progesterone, be prescribed during pregnancy)
Evidence: 0.35
¬ Typical(progesterone, be given during pregnancy)
0.62
Rule weight: 0.85
Evidence weight: 0.83
Similarity weight: 0.88
Evidence: 0.82
Salient(progesterone, be prescribed during pregnancy)
Evidence: 0.95
¬ Salient(progesterone, be prescribed after iui)
0.62
Rule weight: 0.85
Evidence weight: 0.74
Similarity weight: 0.99
Evidence: 0.61
Plausible(progesterone, be prescribed during pregnancy)
Evidence: 0.67
¬ Plausible(progesterone, be prescribed in pregnancy)
0.62
Rule weight: 0.85
Evidence weight: 0.82
Similarity weight: 0.88
Evidence: 0.82
Salient(progesterone, be prescribed during pregnancy)
Evidence: 0.98
¬ Salient(progesterone, be important during pregnancy)
0.61
Rule weight: 0.85
Evidence weight: 0.80
Similarity weight: 0.89
Evidence: 0.61
Plausible(progesterone, be prescribed during pregnancy)
Evidence: 0.50
¬ Plausible(progesterone, be given during pregnancy)
0.59
Rule weight: 0.85
Evidence weight: 0.71
Similarity weight: 0.99
Evidence: 0.50
Typical(progesterone, be prescribed during pregnancy)
Evidence: 0.59
¬ Typical(progesterone, be prescribed in pregnancy)
0.55
Rule weight: 0.85
Evidence weight: 0.66
Similarity weight: 0.98
Evidence: 0.61
Plausible(progesterone, be prescribed during pregnancy)
Evidence: 0.86
¬ Plausible(progesterone, be prescribed in early pregnancy)
0.55
Rule weight: 0.85
Evidence weight: 0.73
Similarity weight: 0.88
Evidence: 0.61
Plausible(progesterone, be prescribed during pregnancy)
Evidence: 0.69
¬ Plausible(progesterone, be needed during pregnancy)
0.53
Rule weight: 0.85
Evidence weight: 0.70
Similarity weight: 0.88
Evidence: 0.50
Typical(progesterone, be prescribed during pregnancy)
Evidence: 0.61
¬ Typical(progesterone, be needed during pregnancy)
0.52
Rule weight: 0.85
Evidence weight: 0.69
Similarity weight: 0.90
Evidence: 0.61
Plausible(progesterone, be prescribed during pregnancy)
Evidence: 0.80
¬ Plausible(progesterone, be prescribed during menopause)
0.50
Rule weight: 0.85
Evidence weight: 0.66
Similarity weight: 0.88
Evidence: 0.61
Plausible(progesterone, be prescribed during pregnancy)
Evidence: 0.86
¬ Plausible(progesterone, be prescribed after iui)
0.48
Rule weight: 0.85
Evidence weight: 0.64
Similarity weight: 0.88
Evidence: 0.61
Plausible(progesterone, be prescribed during pregnancy)
Evidence: 0.92
¬ Plausible(progesterone, be important during pregnancy)
0.47
Rule weight: 0.85
Evidence weight: 0.62
Similarity weight: 0.90
Evidence: 0.50
Typical(progesterone, be prescribed during pregnancy)
Evidence: 0.78
¬ Typical(progesterone, be prescribed during menopause)
0.46
Rule weight: 0.85
Evidence weight: 0.55
Similarity weight: 0.98
Evidence: 0.50
Typical(progesterone, be prescribed during pregnancy)
Evidence: 0.91
¬ Typical(progesterone, be prescribed in early pregnancy)
0.43
Rule weight: 0.85
Evidence weight: 0.57
Similarity weight: 0.88
Evidence: 0.50
Typical(progesterone, be prescribed during pregnancy)
Evidence: 0.87
¬ Typical(progesterone, be prescribed after iui)
0.40
Rule weight: 0.85
Evidence weight: 0.53
Similarity weight: 0.88
Evidence: 0.50
Typical(progesterone, be prescribed during pregnancy)
Evidence: 0.94
¬ Typical(progesterone, be important during pregnancy)

Typical and Remarkable implies Salient

0.13
Rule weight: 0.14
Evidence weight: 0.92
Similarity weight: 1.00
Evidence: 0.82
Salient(progesterone, be prescribed during pregnancy)
Evidence: 0.50
¬ Typical(progesterone, be prescribed during pregnancy)
Evidence: 0.86
¬ Remarkable(progesterone, be prescribed during pregnancy)

Typical implies Plausible

0.38
Rule weight: 0.48
Evidence weight: 0.80
Similarity weight: 1.00
Evidence: 0.61
Plausible(progesterone, be prescribed during pregnancy)
Evidence: 0.50
¬ Typical(progesterone, be prescribed during pregnancy)

Typicality and Rermarkability incompatibility between siblings

0.10
Rule weight: 0.14
Evidence weight: 0.81
Similarity weight: 0.89
Evidence: 0.86
¬ Remarkable(progesterone, be prescribed during pregnancy)
Evidence: 0.23
¬ Typical(oxytocin, be used in pregnancy)